In isolated CD31+ ECs from control and shFGF2 NPC tumor tissues, knockdown FGF2 in NPC tumor cells significantly reduced MYC expression in tumor-associated ECs (Fig. 4H and Supplementary Fig. S4E). The gene discussed is FGF2; the disease is neoplasm.